Gustavo Leal
Researcher in psychiatry and neuropsychopharmacology at the Universidade Federal da Bahia / Hospital Universitário Professor Edgard Santos
Papers
Trials
Key Impact
He is a notable clinical ketamine/esketamine researcher with multiple human studies on arketamine, esketamine, and treatment-resistant depression.
Background & Research
Gustavo C. Leal appears as an author on several clinical studies of ketamine, esketamine, and arketamine for treatment-resistant depression, including randomized, open-label, and retrospective designs. PubMed affiliations on these papers place him in neuropsychopharmacology and psychiatry groups associated with the Universidade Federal da Bahia in Salvador, Brazil, and in some studies he is linked to Stanford University via coaffiliation contexts.
Collaboration Network
4 collaborators· click a node to visit their profile
Full network →